Pests, unhealthy plants, inconsistent harvests, and the high expenses of maintaining mother rooms are just some of the many “growing pains” that cannabis cultivators have experienced over the years. To compound matters, until cannabis legalization, growers had no options but to buy all of their plantlets and other nursery-level products from somewhat questionable sources.
As the cannabis industry emerged out of the shadows after legalization, it became clear that cannabis growers needed access to clean, healthy, and predictable plantlets.
In just over one year, Conception Nurseries revolutionized the industry by taking away the grower’s pain points, while delivering next-generation science and technology to accelerate cannabis cultivation within the rapidly growing health and wellness market. The company leverages innovative tissue culture propagation technology to mass produce high-quality, disease-free cannabis clones, which offer consistent genetic strains and eliminate or reduce the space required for mom rooms. When growers purchase these clones, they can increase their yields, reduce risk and have a more dependable, consistent product.
Using tissue culture micropropagation, Conception Nurseries provides cultivators with elite cannabis clones without using seeds or pollination. “With our clean and genetically certified cannabis clones, we make it easier for growers to focus on growing, rather than managing their nurseries,” says Kevin Brooks, CEO at Conception Nurseries.
Conception Nurseries’ approach is highly scalable and it delivers smaller, higher-volume plants at a much lower price point than its competition. “We can scale very much on demand with a superior level of automation, and innovative technology beyond what’s currently available in the cannabis space," states Brooks.
Tissue culture clones reduce the cost and expense for growers.
Using them can eliminate the need for mother rooms, which take up valuable real estate in an already highly restricted business, require extensive maintenance, and can produce inconsistent yields. By switching over to tissue culture, Conception Nurseries lets growers bank on a more risk-free alternative and convert their real estate and maintenance costs for mother rooms into an additional production area.
A Closer Look at Tissue Culture Micropropagation
Tissue culture micropropagation is used to breed clones in a sterile production environment, which significantly reduces disease, pests, and pathogens. Conception Nurseries’ scalable micropropagation facilities allow the company to rapidly clone cannabis plants with desirable traits and elite genetics.
Using internal growth chambers and a fully automated system, Conception Nurseries curates their “media,” which is a gel that houses their plants, and automates the entire process through to the final hardening of roots, acclimatizing the plants for whichever environment they might end up in. “Typically, in the industry, there’s about an 8 to 13 percent failure rate of plants. Our plants, however, have produced results at a failure rate less than 2 percent,” says Brooks. As a result, our customers receive a year-round supply of pest and contamination-free clones, while increasing their revenue.”
Apart from its immaculately conceived clones, Conception Nurseries boasts a “true-clone system,” consisting of restoration services where the company takes in genetic specifications for cannabis plants provided by its customer and restores them to their original health and vigor, returning a cleaner and healthier plant.
Conception Nurseries is determined to steadily incorporate tissue agriculture technology and elite genetics into the cannabis market to address the problems in the supply chain. For example, sick, unhealthy, and underperforming plants at the very initial stage impact everything across the supply chain. Conception Nurseries focuses on applying the most advanced forms of tissue agriculture technology to stabilize the supply chain and produce healthy, clean, vigorous clones at the front end. The company has been actively signing long-term engagements with commercial growers and plans to continue onboarding those commercial growers to provide them with additional solutions.
Conception Nurseries is also looking forward to opening a new facility in Canada and across the US. “We will continue to demonstrate that we can produce tissue culture plants at a scale that has never been done before, and by the end of this year, we expect to be the single largest producer of cannabis plants in the world,” concludes Brooks.